Purpose Bio is developing proprietary novel therapeutics to treat metabolic syndrome diseases. 

Our therapeutics are working upstream of other solutions. We are working hard to develop the safest, most tolerable efficacious solution to hundred of millions patients around the world. 

Our first focused indications are MASLD/MASH: Metabolic dysfunction-associated steatohepatitis liver disease, Hyperlipidemia and Obesity. 

contact us: lital@purposebio.com